查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953945

診斷心電圖市場 - 全球產業規模、佔有率、趨勢、機會及預測（依產品類型、通路、最終用途、地區及競爭格局分類，2021-2031年）

Diagnostic Electrocardiograph Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Channel, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球診斷心電圖市場預計將從 2025 年的 84.8 億美元成長到 2031 年的 128.1 億美元，複合年成長率為 7.12%。

這些設備旨在捕捉並記錄特定時間內的心臟電活動，是檢測心肌梗塞和心律不整等心臟異常的重要工具。推動該市場發展的主要經濟因素是全球心血管疾病盛行率的上升，這使得頻繁且準確的心臟監測對於有效的患者照護至關重要。此外，儘管技術不斷進步，但老年人口的成長（老年人更容易患慢性心臟疾病）仍持續推動著對這些診斷設備的基本需求。

市場概覽
預測期 2027-2031
市場規模：2025年 84.8億美元
市場規模：2031年 128.1億美元
複合年成長率：2026-2031年 7.12%
成長最快的細分市場 心臟護理中心
最大的市場 北美洲

儘管成長指標強勁，但由於缺乏能夠準確解讀複雜心電圖結果的熟練醫務人員，該行業仍面臨許多挑戰。這可能導致診斷瓶頸，阻礙高效率的工作流程。鑑於需要治療的患者數量龐大，醫療保健系統承受著巨大的壓力。根據美國心臟協會預測，到2024年，美國將有約1.269億成年人患有某種形式的心血管疾病。如此巨大的疾病負擔凸顯了對便捷的診斷解決方案和訓練有素的醫務人員進行有效診療的迫切需求。

市場促進因素

將人工智慧 (AI) 和機器學習技術應用於心電圖判讀，正在成為市場上的變革力量，從根本上改變了診斷流程和可近性。這些技術透過自動檢測複雜心律不整，提高了臨床診斷的準確性和速度，從而緩解了專科醫生嚴重短缺的問題，同時也促進了先進診斷工具在非醫院環境中的應用。這項技術進步正在迅速擴展硬體的功能。例如，Healio 在 2024 年 6 月報道稱，FDA 已核准一款新型的 AI 賦能攜帶式12 導聯心電圖系統，該系統能夠區分 35 種不同的心臟觀察，顯著提升了攜帶式設備在即時應用中的診斷效用。

同時，穿戴式和攜帶式心電圖監測設備的快速普及，透過實現持續的遠端心電圖監測，正在改變患者照護方式。這一趨勢推動了整個行業向門診護理的轉變，使醫療系統能夠在維持嚴格監測標準的同時，降低與長期住院相關的成本。這些遠端解決方案的臨床和經濟價值是市場上的關鍵差異化因素。皇家飛利浦公司2024年5月發布的新聞稿重點介紹了一項研究，該研究表明，使用行動門診心臟遙測的患者再入院率（30.2%）顯著低於使用植入式循環記錄儀的患者（35.4%）。隨著心臟護理經濟影響的不斷擴大，這種效率的提升至關重要。美國心臟協會在2024年預測，到2050年，美國與心血管疾病相關的年度醫療費用將增加近四倍，達到1.49兆美元。

市場挑戰

熟練醫療專業人員的短缺是診斷性心電圖市場成長的主要阻礙因素。儘管對心臟監測的需求不斷成長，但由於訓練有素的技術人員和心臟病專家的短缺，處理和解讀診斷數據的能力受到限制。這種短缺造成了營運瓶頸，患者吞吐量受限於結果分析的速度，而非設備的可用性。因此，醫療機構可能會推遲購買額外的心電圖設備，因為在人員沒有相應增加的情況下增加硬體庫存並不能轉化為患者管理整體效率的提高。

診斷程序需求量與可用醫護人員數量之間的不平衡直接影響市場收入。醫院被迫優先處理現有病例，而非投資擴充設備，導致設備更新週期延長，採購率降低。近期行業數據也印證了這項醫護人員短缺問題的嚴重性。 2024年，美國醫學院協會（AAMC）報告稱，預計到2036年，美國將面臨高達8.6萬名醫生的缺口。專科醫務人員的持續短缺凸顯了複雜診斷能力的不足，從而限制了製造商的潛在市場規模。

市場趨勢

智慧型手機連接的攜帶式心電圖儀正從消費級醫療保健領域向嚴謹的臨床應用領域發展，利用大型資料集實現醫療級精準度。這些設備透過採用與傳統12導聯系統相媲美的深度學習模型，將先進的診斷功能直接賦予患者，從而改變全球診斷心電圖市場。這種能力的提升得益於海量心臟數據的積累，這些數據不斷最佳化檢測演算法，使其能夠即時應用於臨床診療。根據《心血管商業》（Cardiovascular Business）2024年6月的一篇報導報道，新核准的KAI 12L技術基於超過175萬份心電圖進行訓練，使這款攜帶式設備能夠識別包括心肌梗塞在內的多種疾病。

同時，隨著製造商克服訊號雜訊和資料過載等歷史難題，無線和無導線心電圖架構（尤其是植入式心臟監視器 (ICM)）的普及速度正在加快。與傳統的外部貼片和有線動態心電圖監測不同，這些無導線植入可提供長期皮下監測，但以往卻因大量誤報而給臨床醫生帶來負擔。近期技術進步已將先進演算法直接整合到這些無導線設計中，透過在傳輸前過濾非臨床偽影來提高診斷準確性和操作效率。例如，《心臟節律新聞》在2024年4月報道，採用SmartECG技術的新型Biomonitor IV植入式心臟監視器可整體主要心律不整的誤報率降低86%，從而顯著簡化醫療團隊的審查流程。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球診斷心電圖市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（靜態心電圖設備、動態心電圖設備、心電圖監測、其他）
    • 按通道數（12通道、6通道、5通道、3通道、單通道）
    • 依用途（醫院/診所、門診手術中心、心臟護理中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美診斷心電圖市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲診斷心電圖市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區診斷心電圖市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲診斷心電圖市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲診斷心電圖市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球診斷心電圖市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • General Electric Company
  • Koninklijke Philips NV
  • Nihon Kohden Corporation
  • Ambu A/S
  • Spacelabs Healthcare, Inc.
  • AliveCor, Inc.
  • Mindray Medical India Pvt. Ltd.
  • Hill-Rom Holdings, Inc.
  • Bpl Medical Technologies Pvt. Ltd.
  • Bardy Diagnostics, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7413

The Global Diagnostic Electrocardiograph Market is projected to expand from USD 8.48 Billion in 2025 to USD 12.81 Billion by 2031, registering a CAGR of 7.12%. These devices, designed to capture and record the heart's electrical activity over specific durations, serve as essential tools for detecting cardiac abnormalities like myocardial infarctions and arrhythmias. The primary economic force driving this market is the rising global prevalence of cardiovascular diseases, which necessitates frequent and precise cardiac monitoring for effective patient care. Additionally, the growing geriatric population, a demographic statistically more prone to chronic heart conditions, continues to reinforce the fundamental demand for these diagnostic instruments, irrespective of technological advancements.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.48 Billion
Market Size 2031USD 12.81 Billion
CAGR 2026-20317.12%
Fastest Growing SegmentCardiac Care Centers
Largest MarketNorth America

Despite these strong growth indicators, the industry faces a substantial hurdle due to a shortage of skilled healthcare professionals qualified to accurately interpret complex electrocardiogram results, which can cause diagnostic bottlenecks and hinder efficient workflows. This strain on healthcare systems is significant considering the high volume of patients requiring attention. As reported by the American Heart Association in 2024, approximately 126.9 million adults in the United States were living with some form of cardiovascular disease. This immense disease burden highlights the critical need for accessible diagnostic solutions and a trained workforce to manage the caseload effectively.

Market Driver

The integration of Artificial Intelligence and Machine Learning into ECG interpretation represents a transformative force in the market, fundamentally changing diagnostic workflows and accessibility. These technologies help mitigate the critical shortage of specialists by automating the detection of complex arrhythmias, thereby improving clinical accuracy and speed while facilitating the deployment of advanced diagnostic tools in non-hospital environments. This technological progression is rapidly broadening hardware capabilities; for instance, Healio reported in June 2024 that the FDA cleared a new AI-enabled handheld 12-lead ECG system capable of identifying 35 different cardiac determinations, significantly expanding the diagnostic utility of portable devices for immediate clinical use.

Concurrently, the rapid proliferation of wearable and portable ECG monitoring devices is reshaping patient management by enabling continuous, remote cardiac surveillance. This trend supports the industry-wide shift toward ambulatory care, allowing healthcare systems to reduce costs associated with long-term hospitalization while maintaining rigorous oversight standards. The clinical and economic value of these remote solutions is a key market differentiator; a May 2024 press release from Royal Philips highlighted a study showing that patients utilizing mobile cardiac outpatient telemetry had a significantly lower readmission rate of 30.2% compared to 35.4% for those with implantable loop recorders. Such efficiency is vital as the economic impact of heart care grows, with the American Heart Association projecting in 2024 that annual U.S. health care costs for cardiovascular conditions will nearly quadruple to $1,490 billion by 2050.

Market Challenge

The scarcity of skilled healthcare professionals acts as a major constraint on the growth of the diagnostic electrocardiograph market. Although the demand for cardiac monitoring is increasing, the capacity to process and interpret the resulting diagnostic data is limited by a lack of trained technicians and cardiologists. This deficit creates operational bottlenecks where patient throughput is restricted not by device availability, but by the speed of result analysis. Consequently, healthcare facilities may delay purchasing additional electrocardiograph units, as increasing hardware inventories without a corresponding increase in workforce capacity fails to improve overall patient management efficiency.

This imbalance between the volume of required diagnostic procedures and the available workforce directly impacts market revenue. Hospitals are forced to prioritize managing existing caseloads rather than investing in fleet expansion, leading to extended replacement cycles and reduced procurement rates. The severity of this workforce issue is underscored by recent industry data; the Association of American Medical Colleges reported in 2024 that the United States faces a projected shortage of up to 86,000 physicians by 2036. This persistent lack of specialty care providers highlights the limited capacity to handle complex diagnostics, thereby restricting the total addressable market for manufacturers.

Market Trends

The evolution of smartphone-connected handheld ECG devices is shifting beyond consumer wellness into rigorous clinical application, utilizing massive datasets to achieve medical-grade precision. These devices are transforming the Global Diagnostic Electrocardiograph Market by placing sophisticated diagnostic capabilities directly into patients' hands, supported by deep learning models that rival traditional 12-lead systems. This capability is driven by the aggregation of vast amounts of cardiac data which refines detection algorithms for immediate point-of-care use; according to a June 2024 Cardiovascular Business article, the newly approved KAI 12L technology was trained on data from over 1.75 million ECGs, enabling the handheld device to provide determinations for a wide range of conditions, including myocardial infarctions.

Simultaneously, the adoption of wireless and leadless ECG architectures, particularly insertable cardiac monitors (ICMs), is accelerating as manufacturers resolve historical issues regarding signal noise and data overload. Unlike traditional external patches or wired Holter monitors, these leadless implants offer long-term subcutaneous monitoring but have previously burdened clinicians with high volumes of false alerts. Recent advancements now integrate sophisticated algorithms directly into these leadless designs to filter non-clinical artifacts before transmission, enhancing diagnostic yield and operational efficiency. For instance, Cardiac Rhythm News reported in April 2024 that the new Biomonitor IV insertable cardiac monitor features SmartECG technology that reduces false detections by 86% across all major arrhythmias, significantly streamlining the review process for care teams.

Key Market Players

  • General Electric Company
  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Ambu A/S
  • Spacelabs Healthcare, Inc.
  • AliveCor, Inc.
  • Mindray Medical India Pvt. Ltd.
  • Hill-Rom Holdings, Inc.
  • Bpl Medical Technologies Pvt. Ltd.
  • Bardy Diagnostics, Inc.

Report Scope

In this report, the Global Diagnostic Electrocardiograph Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Electrocardiograph Market, By Product Type

  • Resting ECG Devices
  • Stress ECG Devices
  • Holter Monitors
  • Others

Diagnostic Electrocardiograph Market, By Channel

  • 12-channel
  • 6-channel
  • 5- channel
  • 3- channel
  • Single- channel

Diagnostic Electrocardiograph Market, By End Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Cardiac Care Centers
  • Others

Diagnostic Electrocardiograph Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Electrocardiograph Market.

Available Customizations:

Global Diagnostic Electrocardiograph Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diagnostic Electrocardiograph Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Others)
    • 5.2.2. By Channel (12-channel, 6-channel, 5- channel, 3- channel, Single- channel)
    • 5.2.3. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Cardiac Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Diagnostic Electrocardiograph Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Channel
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diagnostic Electrocardiograph Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Channel
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Diagnostic Electrocardiograph Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Channel
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Diagnostic Electrocardiograph Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Channel
        • 6.3.3.2.3. By End Use

7. Europe Diagnostic Electrocardiograph Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Channel
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Diagnostic Electrocardiograph Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Channel
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Diagnostic Electrocardiograph Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Channel
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Diagnostic Electrocardiograph Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Channel
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Diagnostic Electrocardiograph Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Channel
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Diagnostic Electrocardiograph Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Channel
        • 7.3.5.2.3. By End Use

8. Asia Pacific Diagnostic Electrocardiograph Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Channel
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Diagnostic Electrocardiograph Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Channel
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Diagnostic Electrocardiograph Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Channel
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Diagnostic Electrocardiograph Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Channel
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Diagnostic Electrocardiograph Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Channel
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Diagnostic Electrocardiograph Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Channel
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Diagnostic Electrocardiograph Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Channel
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Diagnostic Electrocardiograph Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Channel
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Diagnostic Electrocardiograph Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Channel
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Diagnostic Electrocardiograph Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Channel
        • 9.3.3.2.3. By End Use

10. South America Diagnostic Electrocardiograph Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Channel
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Diagnostic Electrocardiograph Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Channel
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Diagnostic Electrocardiograph Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Channel
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Diagnostic Electrocardiograph Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Channel
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Diagnostic Electrocardiograph Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. General Electric Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Koninklijke Philips N.V.
  • 15.3. Nihon Kohden Corporation
  • 15.4. Ambu A/S
  • 15.5. Spacelabs Healthcare, Inc.
  • 15.6. AliveCor, Inc.
  • 15.7. Mindray Medical India Pvt. Ltd.
  • 15.8. Hill-Rom Holdings, Inc.
  • 15.9. Bpl Medical Technologies Pvt. Ltd.
  • 15.10. Bardy Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer